Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers
NCT03623984
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
no partipants
Conditions
Neuroendocrine Carcinoma of Pancreas
Carcinoid
Interventions
DRUG:
Gallium Dotatate
Sponsor
University of Alabama at Birmingham